Brief: AnPac Bio's First Disease Treatment Patent Granted, Cancer Treatment Project Secured Funds
18/06/2021 11:50
June 18 (Reuters) - AnPac Bio-Medical Science Co Ltd
ANPC.O :
* ANPAC BIO’S FIRST DISEASE TREATMENT PATENT GRANTED, AND
ITS
CANCER TREATMENT PROJECT SECURED MULTI-MILLION DOLLAR FUNDS
* ANPAC BIO-MEDICAL SCIENCE CO LTD - PATENT COVERS NOVEL
MEDICAL
DEVICES FOR BOTH DISEASE DETECTION AND TREATMENT APPLICATIONS
AND HAS 25 CLAIMS
* ANPAC BIO-MEDICAL SCIENCE - CANCER TREATMENT JV HAS
SECURED OVER
4 MILLION US DOLLARS OF CAPITAL CONTRIBUTIONS FROM MULTIPLE
FUNDING SOURCES
Source text for Eikon: ID:nGNXb3PpmK
Further company coverage: ANPC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh2
See all newsBrief: Fresh2 Group On Dec 20, Received Nasdaq Notice That It Will Be Delisted From Nasdaq Capital Market Effective At Open Of Market On Dec 24
Brief: Fresh2 Group Ltd. Announces Receipt Of Staff Delisting Determination From Nasdaq Intends To Request A Hearing
Brief: Fresh2 Group Ltd Announces Receipt Of A Delinquency Compliance Alert Notice From Nasdaq
Brief: Anpac Bio-Medical Science - In Dec 2022 And Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors
Brief: AnPac Bio Granted Continued Listing By Nasdaq Hearing Panel, Subject To Meeting $1 Bid Price Compliance Rule On Or Before Nov. 23, 2022